Protecting children from nerve agents
by Wally Northway
Published: October 4,2013
By Wally Northway
While Mississippi State University scientists work on an antidote for nerve agents for use by the military, the federal government is looking for nerve agent treatments for children.
According to a release from the U.S. Department of Health and Human Services, an effective, faster-acting and longer-lasting pediatric medication to treat seizures caused by nerve agents will be studied and purchased under a Project BioShield contract from HHS’ Office of the Assistant Secretary for Preparedness and Response.
There are no currently approved medications to treat seizures caused by nerve agents, HHS reports.
Under a five-year, $60-million contract, Meridian Medical Technologies Inc. of Columbia, Md., a Pfizer company, will conduct studies of midazolam to seek approval from the U.S. Food and Drug Administration for the drug’s use in treating seizures caused by nerve agents. Meridian also will seek FDA approval of a midazolam auto-injector for children and adults, and seek approval of midazolam for use in treating common prolonged seizures.
To sign up for Mississippi Business Daily Updates, click here.
One Response to “Protecting children from nerve agents”
Top Posts & Pages
- George’s Girls put shopping skills to work
- Justice Department files complaint against tax preparer
- DMR pays accounting firm more than double contract's worth
- Following ruling, Entergy to hand over records to county
- Report: State's emergency care ranks highest in Southeast
- Boyd Gaming reports drop in in-state net revenue
- Union-restricting legislation moves forward
- Chris McDaniel gets a thank you note from Travis Childers
- USM staffers Olivia Hurst and Catherine Lott recognized by Public Relations Association of Mississippi